FHNH First reports no available quarterly earnings or revenue data for its Series H preferred shares BTAI BioXcel posts narrower than expected Q4 2025 loss even as shares drop 364 percent in todays trading KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today